IMRIS Inc. (Nasdaq: IMRS) announced US Food and Drug Administration clearance of the newest generation VISIUS Surgical Theatre which integrates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE